Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 49,868 | 17,806 | -28,239 | -10,594 | -13,160 |
| Depreciation Amortization | 4,570 | 2,331 | 10,783 | 8,012 | 5,235 |
| Accounts receivable | -2,692 | -22,200 | -11,916 | -15,814 | -21,227 |
| Accounts payable and accrued liabilities | -1,410 | 447 | 3,839 | -1,155 | -1,145 |
| Other Working Capital | -16,038 | -24,519 | -10,123 | -13,727 | -17,588 |
| Other Operating Activity | 9,130 | 23,917 | 44,456 | 24,481 | 27,103 |
| Operating Cash Flow | $43,428 | $-2,218 | $8,800 | $-8,797 | $-20,782 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,413 | -2,347 | -4,771 | -3,574 | -2,817 |
| Purchase Sale Intangibles | -314 | -15 | -210 | 0 | N/A |
| Other Investing Activity | -314 | -15 | -210 | 0 | 0 |
| Investing Cash Flow | $-4,727 | $-2,362 | $-4,981 | $-3,574 | $-2,817 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 135,000 | N/A | N/A |
| Debt Repayment | N/A | N/A | -171,327 | -16 | -16 |
| Common Stock Issued | 1,360 | 1,029 | 1,104 | 1,096 | 472 |
| Other Financing Activity | -3,169 | -2,476 | -3,766 | -1,074 | -866 |
| Financing Cash Flow | $-1,809 | $-1,447 | $-38,989 | $6 | $-410 |
| Beginning Cash Position | 51,352 | 51,352 | 86,522 | 86,522 | 86,522 |
| End Cash Position | 88,244 | 45,325 | 51,352 | 74,157 | 62,513 |
| Net Cash Flow | $36,892 | $-6,027 | $-35,170 | $-12,365 | $-24,009 |
| Free Cash Flow | |||||
| Operating Cash Flow | 43,428 | -2,218 | 8,800 | -8,797 | -20,782 |
| Capital Expenditure | -4,413 | -2,347 | -4,771 | -3,574 | -2,817 |
| Free Cash Flow | 39,015 | -4,565 | 4,029 | -12,371 | -23,599 |